NNIT A/S: NNIT improved profitability amid negative growth due to market uncertainty

Core Insights - The IT Life Science consultancy industry is experiencing a slowdown due to geopolitical unrest, leading to lower customer engagement and project initiation [2][5] - NNIT is adapting its operating model and market strategy to focus on repeatable solutions across regions while reducing overhead costs [2][5] Financial Performance - In Q2 2025, NNIT reported revenue of DKK 462.2 million, a decline of 2.5% compared to Q2 2024, with organic growth down by 1.7% [4][5] - Group operating profit excluding special items was DKK 22.9 million, resulting in a margin of 5.0%, which is lower than the same quarter last year [4][5] - Special items for the quarter amounted to DKK 20.3 million, impacting overall profitability [4] Market Outlook - The company expects to end the full year within the lower end of the guided range for both organic growth (0% to 5%) and group operating profit margin excluding special items (7% to 9%) due to ongoing macroeconomic challenges [5] - There are early signs of improvement in demand for IT Life Science services, particularly in the US region, which has returned to growth [5]